Vaccination: Overview
What it does
The job the technology does for people, in a short paragraph
Vaccination protects people from infectious disease by training the immune system before the germ arrives. Edward Jenner showed it in 1796, using cowpox against smallpox [1]. Smallpox was declared eradicated in 1980 [1], and vaccines against 14 pathogens in WHO's routine programme have averted about 154 million deaths since 1974 [3]. In 2024, 85% of the world's infants received all three doses of the diphtheria, tetanus and whooping cough vaccine [4].
as of 2026-11-10
How it works
The working principle in plain words, step by step
When a new germ infects the body, the immune system needs days to find the right defence, and the disease can win in that time. A vaccine gives the body a safe preview. It holds a harmless relative of the germ, such as cowpox, a weakened or killed germ, or just one of the germ's molecules. White blood cells meet these molecules, called antigens, and make antibodies and cells that recognise them. Some of those cells stay on as a memory. When the real germ arrives, the memory cells react within hours, before the disease takes hold. Many vaccines add an adjuvant, often an aluminium salt, that strengthens the response [7]. When enough people are immune, the germ finds too few hosts to spread, which also shields the unvaccinated.
as of 2026-11-10
Key figures
The handful of numbers that size it up, each with its unit, year and source
| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| Deaths averted by vaccination since 1974 | 154 | million deaths | 2024 | [3] |
| Infants completing three doses of DTP vaccine | 85 | % | 2024 | [4] |
| Infants who received no vaccine at all | 14.3 | million infants | 2024 | [4] |
| Vaccine doses supplied worldwide | 16 | billion doses | 2021 | [5] |
| Value of vaccines supplied worldwide | 141 | billion USD | 2021 | [5] |
as of 2026-11-10. The 2021 doses and value include COVID-19 vaccines; in 2019 the market was 5.8 billion doses worth US$38 billion [5].
Where it is used
The main places and products the technology is found in
- Routine childhood immunisation against measles, diphtheria, tetanus, whooping cough and other diseases [4]
- Seasonal flu vaccination, mostly with vaccines made by a process that uses chicken eggs [6]
- Mass eradication campaigns, such as the smallpox programme that ended in 1980 [1]
- Pandemic response, which nearly tripled the number of doses supplied between 2019 and 2021 [5]
- Vaccines for travellers, health workers and people at risk in outbreaks
as of 2026-11-10
Scale today
How much of it there is now: units in use, made each year and who uses it
- Made per year
- About 16 billion doses supplied in 2021, 5.8 billion in 2019 [5]
- Users
- About 109 million infants completed the three-dose DTP series in 2024 [4]
- Unit
- doses; infants
- Year
- 2024
- Note
- Doses are for 2021, a year swollen by COVID-19 vaccines; infants are for 2024.
as of 2026-11-10
Sources
- History of Smallpox US Centers for Disease Control and Prevention
- New data shows vaccines have saved 154 million lives in the past 50 years Gavi, the Vaccine Alliance (VaccinesWork), 2024
- Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated: WHO, UNICEF World Health Organization and UNICEF, 2025
- WHO releases first data on global vaccine market since COVID-19 World Health Organization, 2022
- How Influenza (Flu) Vaccines Are Made US Centers for Disease Control and Prevention
- Adjuvants and Vaccines US Centers for Disease Control and Prevention